Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up

Expert Review of Hematology

Volumn 4, Issue 4, 2011, Pages 437-454

  Bhatia, Smita ^a  

^a Department of Population Sciences City of Hope ^*  (United States)

Author keywords

hematopoietic stem cell transplantation; late effects; long term follow up guidelines

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; BLEOMYCIN; CALCINEURIN INHIBITOR; CARMUSTINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GYRASE INHIBITOR; IFOSFAMIDE; METHOTREXATE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLATINUM DERIVATIVE; PREDNISONE; RAPAMYCIN; RITUXIMAB; TACROLIMUS;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; AVASCULAR NECROSIS; BASAL CELL CARCINOMA; BREAST CANCER; BRONCHIOLITIS OBLITERANS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CARDIOMYOPATHY; CARDIOPULMONARY INSUFFICIENCY; CARDIOTOXICITY; CARDIOVASCULAR RISK; CATARACT; CELL THERAPY; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; CYTOPENIA; DIABETES MELLITUS; DRUG MEGADOSE; DYSLIPIDEMIA; ENDOCRINE DISEASE; FOLLOW UP; GLUCOSE INTOLERANCE; GONAD DYSFUNCTION; GRAFT VERSUS HOST REACTION; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; HEALTH BEHAVIOR; HEALTH CARE UTILIZATION; HEART DISEASE; HEART INFARCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPERTENSION; HYPOGONADISM; HYPOTHYROIDISM; INTERSTITIAL PNEUMONIA; KIDNEY FAILURE; LIFE EXPECTANCY; LUNG FIBROSIS; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MALE INFERTILITY; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; MUSCULOSKELETAL DISEASE; MYELODYSPLASTIC SYNDROME; OSTEOPENIA; OSTEOPOROSIS; PNEUMONIA; POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SHORT STATURE; SKIN CANCER; SQUAMOUS CELL CARCINOMA; SURVIVOR; THYROID CANCER; THYROID DISEASE; TREATMENT OUTCOME; WHOLE BODY RADIATION;

FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; SURVIVORS;

EID: 79961080747     PISSN: 17474086     EISSN: 17474094     Source Type: Journal    
DOI: 10.1586/ehm.11.39     Document Type: Review

References (110)

1. Bhatia S, Francisco L, Carter A et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 110(10), 3784-3792 (2007). (Pubitemid 350159650)
2. Bhatia S, Robison LL, Francisco L et al. Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood 105(11), 4215-4222 (2005). (Pubitemid 40720765)
3. Socie G, Stone JV, Wingard JR et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N. Engl. J. Med. 341(1), 14-21 (1999).
4. Armenian SH, Sun CL, Francisco L et al. Late congestive heart failure after hematopoietic cell transplantation. J. Clin. Oncol. 26(34), 5537-5543 (2008).
5. Baker KS, Ness KK, Steinberger J et al. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study. Blood 109(4), 1765-1772 (2007). (Pubitemid 46239613)
6. Brennan BM, Shalet SM. Endocrine late effects after bone marrow transplant. Br. J. Haematol. 118(1), 58-66 (2002). (Pubitemid 34779517)
7. Choi M, Sun CL, Kurian S et al. Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation. Cancer 113(7), 1580-1587 (2008).
8. Fraser CJ, Bhatia S, Ness K et al. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study. Blood 108(8), 2867-2873 (2006).
9. Leiper AD. Non-endocrine late complications of bone marrow transplantation in childhood: part II. Br. J. Haematol. 118(1), 23-43 (2002). (Pubitemid 34779515)
10. Majhail NS, Ness KK, Burns LJ et al. Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Biol. Blood Marrow Transplant. 13(10), 1153-1159 (2007). (Pubitemid 47413009)
11. Rizzo JD, Curtis RE, Socie G et al. Solid cancers after allogeneic hematopoietic cell transplantation. Blood 113(5), 1175-1183 (2009).
12. Sanders JE. Chronic graft-versus-host disease and late effects after hematopoietic stem cell transplantation. Int. J. Hematol. 76(Suppl. 2), 15-28 (2002).
13. Socie G, Salooja N, Cohen A et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood 101(9), 3373-3385 (2003). (Pubitemid 36857917)
14. Wingard JR, Vogelsang GB, Deeg HJ. Stem cell transplantation: supportive care and long-term complications. Hematology (Am. Soc. Hematol. Educ. Program) 422-444 (2002).
15. Yahalom J, Portlock CS. Long-term cardiac and pulmonary complications of cancer therapy. Hematol. Oncol. Clin. North Am. 22(2), 305-318 (2008). (Pubitemid 351452100)
16. Grenier MA, Lipshultz SE. Epidemiology of anthracycline cardiotoxicity in children and adults. Semin. Oncol. 25(4 Suppl. 10), 72-85 (1998). (Pubitemid 28460388)
17. Barry E, Alvarez JA, Scully RE, Miller TL, Lipshultz SE. Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management. Expert Opin Pharmacother. 8(8), 1039-1058 (2007). (Pubitemid 46929299)
18. Majhail NS, Flowers ME, Ness KK et al. High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 43(1), 49-54 (2009).
19. Armenian SH, Bhatia S. Cardiovascular disease after hematopoietic cell transplantation - lessons learned. Haematologica 93(8), 1132-1136 (2008).
20. Tichelli A, Bhatia S, Socie G. Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation. Br. J. Haematol. 142(1), 11-26 (2008). (Pubitemid 351784478)
21. Tichelli A, Passweg J, Wojcik D et al. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica 93(8), 1203-1210 (2008).
22. Tichelli A, Bucher C, Rovo A et al. Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood 110(9), 3463-3471 (2007). (Pubitemid 350106343)
23. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 97(18), 1837-1847 (1998). (Pubitemid 28213628)
24. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. AHA/ACC scientific statement: assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J. Am. Coll. Cardiol. 34(4), 1348-1359 (1999). (Pubitemid 29500569)
25. Armenian SH, Sun CL, Mills G et al. Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation. Biol. Blood Marrow Transplant. 16(8), 1138-1144 (2010).
26. Yoshihara S, Yanik G, Cooke KR, Mineishi S. Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 13(7), 749-759 (2007). (Pubitemid 46902446)
27. Patriarca F, Skert C, Bonifazi F et al. Effect on survival of the development of late-onset non-infectious pulmonary complications after stem cell transplantation. Haematologica 91(9), 1268-1272 (2006). (Pubitemid 44408442)
28. Savani BN, Montero A, Srinivasan R et al. Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation. Biol. Blood Marrow Transplant. 12(12), 1261-1269 (2006). (Pubitemid 44858271)
29. Uderzo C, Pillon M, Corti P et al. Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties. Bone Marrow Transplant. 39(11), 667-675 (2007). (Pubitemid 46813583)
30. Santo Tomas LH, Loberiza FR Jr, Klein JP et al. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest 128(1), 153-161 (2005). (Pubitemid 40994467)
31. Pandya CM, Soubani AO. Bronchiolitis obliterans following hematopoietic stem cell transplantation: a clinical update. Clin. Transplant. 24(3), 291-306 (2010).
32. Bankier AA, Van Muylem A, Knoop C, Estenne M, Gevenois PA. Bronchiolitis obliterans syndrome in heart-lung transplant recipients: diagnosis with expiratory CT. Radiology 218(2), 533-539 (2001). (Pubitemid 32121072)
33. Filipovich AH, Weisdorf D, Pavletic S et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol. Blood Marrow Transplant. 11(12), 945-956 (2005). (Pubitemid 41754712)
34. Tichelli A, Rovo A, Passweg J et al. Late complications after hematopoietic stem cell transplantation. Expert Rev. Hematol. 2(5), 583-601 (2009).
35. Fukuda T, Hackman RC, Guthrie KA et al. Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation. Blood 102(8), 2777-2785 (2003). (Pubitemid 37248846)
36. Wolff D, Reichenberger F, Steiner B et al. Progressive interstitial fibrosis of the lung in sclerodermoid chronic graft-versus-host disease. Bone Marrow Transplant. 29(4), 357-360 (2002). (Pubitemid 34229041)
37. Berger C, Le-Gallo B, Donadieu J et al. Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia. Bone Marrow Transplant. 35(10), 991-995 (2005). (Pubitemid 40711836)
38. Ishiguro H, Yasuda Y, Tomita Y et al. Long-term follow-up of thyroid function in patients who received bone marrow transplantation during childhood and adolescence. J. Clin. Endocrinol. Metab. 89(12), 5981-5986 (2004). (Pubitemid 39628403)
39. Ebeling PR, Thomas DM, Erbas B, Hopper JL, Szer J, Grigg AP. Mechanisms of bone loss following allogeneic and autologous hematopoietic stem cell transplantation. J. Bone Miner. Res. 14, 341-350 (1999).
40. Aisenberg J, Hsieh K, Kalaitzoglou G et al. Bone mineral density in young adult survivors of childhood cancer. J. Pediatr. Hematol. Oncol. 20(3), 241-245 (1998). (Pubitemid 28280901)
41. Atkinson SA, Halton JM, Bradley C, Wu B, Barr RD. Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition. Int. J. Cancer Suppl. 11, 35-39 (1998).
42. Schulte CM, Beelen DW. Bone loss following hematopoietic stem cell transplantation: a long-term follow-up. Blood 103(10), 3635-3643 (2004). (Pubitemid 38596275)
43. Schimmer AD, Minden MD, Keating A. Osteoporosis after blood and marrow transplantation: clinical aspects. Biol. Blood Marrow Transplant. 6(2A), 175-181 (2000).
44. Stern JM, Sullivan KM, Ott SM et al. Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study. Biol. Blood Marrow Transplant. 7(5), 257-264 (2001). (Pubitemid 32591296)
45. Schimmer AD, Mah K, Bordeleau L et al. Decreased bone mineral density is common after autologous blood or marrow transplantation. Bone Marrow Transplant. 28(4), 387-391 (2001). (Pubitemid 32834358)
46. Kaste SC, Shidler TJ, Tong X et al. Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplant. 33(4), 435-441 (2004). (Pubitemid 38313094)
47. Petryk A, Bergemann TL, Polga KM et al. Prospective study of changes in bone mineral density and turnover in children after hematopoietic cell transplantation. J. Clin. Endocrinol. Metab. 91(3), 899-905 (2006). (Pubitemid 43357756)
48. Mattano LA Jr. Strategic approaches to osteoporosis in transplantation. Pediatr. Transplant. 8(Suppl. 5), 51-55 (2004). (Pubitemid 38787576)
49. Annaloro C, Usardi P, Airaghi L et al. Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplant. 41(9), 797-804 (2008). (Pubitemid 351696344)
50. Oudin C, Simeoni MC, Sirvent N et al. Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia. Blood 117(17), 4442-4448 (2011).
51. Cohen A, Bekassy AN, Gaiero A et al. Endocrinological late complications after hematopoietic SCT in children. Bone Marrow Transplant. 41(Suppl. 2), S43-S48 (2008). (Pubitemid 351864707)
52. Chemaitilly W, Sklar CA. Endocrine complications of hematopoietic stem cell transplantation. Endocrinol. Metab. Clin. North Am. 36(4), 983-998; ix (2007). (Pubitemid 350026254)
53. Jung MH, Cho KS, Lee JW et al. Endocrine complications after hematopoietic stem cell transplantation during childhood and adolescence. J. Korean Med. Sci. 24(6), 1071-1077 (2009).
54. Sanders JE. Growth and development after hematopoietic cell transplant in children. Bone Marrow Transplant. 41(2), 223-227 (2008). (Pubitemid 351188921)
55. Sanders JE, Guthrie KA, Hoffmeister PA, Woolfrey AE, Carpenter PA, Appelbaum FR. Final adult height of patients who received hematopoietic cell transplantation in childhood. Blood 105(3), 1348-1354 (2005). (Pubitemid 40170913)
56. Sklar CA, Mertens AC, Mitby P et al. Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J. Clin. Endocrinol. Metab. 87(7), 3136-3141 (2002). (Pubitemid 34816355)
57. Rovo A, Tichelli A, Passweg JR et al. Spermatogenesis in long-term survivors after allogeneic hematopoietic stem cell transplantation is associated with age, time interval since transplantation, and apparently absence of chronic GvHD. Blood 108(3), 1100-1105 (2006). (Pubitemid 44154651)
58. Savani BN, Kozanas E, Shenoy A, Barrett AJ. Recovery of spermatogenesis after total-body irradiation. Blood 108(13), 4292-4294 (2006).
59. Sanders JE. The impact of marrow transplant preparative regimens on subsequent growth and development. The Seattle Marrow Transplant Team. Semin. Hematol. 28(3), 244-249 (1991).
60. Teinturier C, Hartmann O, Valteau- Couanet D, Benhamou E, Bougneres PF. Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure. Bone Marrow Transplant. 22(10), 989-994 (1998). (Pubitemid 28543061)
61. Gulati SC, Van Poznak C. Pregnancy after bone marrow transplantation. J. Clin. Oncol. 16(5), 1978-1985 (1998). (Pubitemid 28234749)
62. Sanders JE, Buckner CD, Amos D et al. Ovarian function following marrow transplantation for aplastic anemia or leukemia. J. Clin. Oncol. 6(5), 813-818 (1988).
63. Schechter T, Finkelstein Y, Doyle J, Koren G. Pregnancy after stem cell transplantation. Can. Fam. Physician 51, 817-818 (2005). (Pubitemid 40872677)
64. Carter A, Robison LL, Francisco L et al. Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study. Bone Marrow Transplant. 37(11), 1023-1029 (2006).
65. Schover LR. Motivation for parenthood after cancer: a review. J. Natl Cancer Inst. Monogr. (34), 2-5 (2005).
66. Dow KH. Having children after breast cancer. Cancer Pract. 2(6), 407-413 (1994).
67. Hammond C, Abrams JR, Syrjala KL. Fertility and risk factors for elevated infertility concern in 10-year hematopoietic cell transplant survivors and case-matched controls. J. Clin. Oncol. 25(23), 3511-3517 (2007). (Pubitemid 47315576)
68. Syrjala KL, Langer SL, Abrams JR, Storer BE, Martin PJ. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J. Clin. Oncol. 23(27), 6596-6606 (2005). (Pubitemid 46190253)
69. Gurney JG, Ness KK, Rosenthal J, Forman SJ, Bhatia S, Baker KS. Visual, auditory, sensory, and motor impairments in long-term survivors of hematopoietic stem cell transplantation performed in childhood: results from the Bone Marrow Transplant Survivor study. Cancer 106(6), 1402-1408 (2006). (Pubitemid 43363921)
70. Campbell S, Sun CL, Kurian S et al. Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation. Cancer 115(18), 4127-4135 (2009).
71. Antignac C, Gubler MC, Leverger G, Broyer M, Habib R. Delayed renal failure with extensive mesangiolysis following bone marrow transplantation. Kidney Int. 35(6), 1336-1344 (1989). (Pubitemid 19167926)
72. Atkinson K, Biggs JC, Hayes J et al. Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes. Br. J. Haematol. 54(1), 59-67 (1983). (Pubitemid 13127196)
73. Cruz DN, Perazella MA, Mahnensmith RL. Bone marrow transplant nephropathy: a case report and review of the literature. J. Am. Soc. Nephrol. 8(1), 166-173 (1997). (Pubitemid 27496527)
74. Glynne P, Powles R, Steele J et al. Renal dysfunction following autologous bone marrow transplantation in adult patients with acute leukemia. Acta Oncol, 35(6), 709-712 (1996). (Pubitemid 26366729)
75. Kist-van Holthe JE, Bresters D, Ahmed- Ousenkova YM et al. Long-term renal function after hemopoietic stem cell transplantation in children. Bone Marrow Transplant. 36(7), 605-610 (2005). (Pubitemid 43115016)
76. Parikh CR, McSweeney PA, Korular D et al. Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney Int. 62(2), 566-573 (2002). (Pubitemid 34779769)
77. Kersting S, Hene RJ, Koomans HA, Verdonck LF. Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 13(10), 1169-1175 (2007). (Pubitemid 47413012)
78. Stevens LA, Levey AS. Measurement of kidney function. Med. Clin. North Am. 89(3), 457-473 (2005). (Pubitemid 40332392)
79. Bray LC, Carey PJ, Proctor SJ, Evans RG, Hamilton PJ. Ocular complications of bone marrow transplantation. Br. J. Ophthalmol. 75(10), 611-614 (1991).
80. Calissendorff BM, Bolme P. Cataract development and outcome of surgery in bone marrow transplanted children. Br. J. Ophthalmol. 77(1), 36-38 (1993). (Pubitemid 23031812)
81. Giri N, Davis EA, Vowels MR. Long-term complications following bone marrow transplantation in children. J. Paediatr. Child Health 29(3), 201-205 (1993). (Pubitemid 23160358)
82. Deeg HJ, Flournoy N, Sullivan KM et al. Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionation. Int. J. Radiat. Oncol. Biol. Phys. 10(7), 957-964 (1984). (Pubitemid 14096078)
83. Fife K, Milan S, Westbrook K, Powles R, Tait D. Risk factors for requiring cataract surgery following total body irradiation. Radiother. Oncol. 33(2), 93-98 (1994).
84. Livesey SJ, Holmes JA, Whittaker JA. Ocular complications of bone marrow transplantation. Eye 3(3), 271-276 (1989). (Pubitemid 20018876)
85. Ozsahin M, Belkacemi Y, Pene F et al. Total-body irradiation and cataract incidence: a randomized comparison of two instantaneous dose rates. Int. J. Radiat. Oncol. Biol. Phys. 28(2), 343-347 (1994). (Pubitemid 24020517)
86. Bhatia S, Ramsay NK, Steinbuch M et al. Malignant neoplasms following bone marrow transplantation. Blood 87(9), 3633-3639 (1996). (Pubitemid 26129591)
87. Witherspoon RP, Fisher LD, Schoch G et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N. Engl. J. Med. 321(12), 784-789 (1989). (Pubitemid 19237425)
88. Krishnan A, Bhatia S, Slovak ML et al. Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood 95(5), 1588-1593 (2000). (Pubitemid 30120817)
89. Vardiman JW, Thiele J, Arber DA et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114(5), 937-951 (2009).
90. Gilliland DG, Gribben JG. Evaluation of the risk of therapy-related MDS/AML after autologous stem cell transplantation. Biol. Blood Marrow Transplant. 8(1), 9-16 (2002). (Pubitemid 34141546)
91. Witherspoon RP, Deeg HJ. Allogeneic bone marrow transplantation for secondary leukemia or myelodysplasia. Haematologica 84(12), 1085-1087 (1999). (Pubitemid 30016581)
92. Yakoub-Agha I, de La Salmoniere P, Ribaud P et al. Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantation. J. Clin. Oncol. 18(5), 963-971 (2000). (Pubitemid 30123771)
93. Bloomfield CD, Archer KJ, Mrozek K et al. 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer 33(4), 362-378 (2002). (Pubitemid 34208798)
94. Litzow MR, Tarima S, Perez WS et al. Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 115(9), 1850-1857 (2010).
95. Landgren O, Gilbert ES, Rizzo JD et al. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood 113(20), 4992-5001 (2009).
96. Schouten HC, Hopman AH, Haesevoets AM, Arends JW. Large-cell anaplastic non-Hodgkin's lymphoma originating in donor cells after allogenic bone marrow transplantation. Br. J. Haematol. 91(1), 162-166 (1995).
97. Rowlings PA, Curtis RE, Passweg JR et al. Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation. J. Clin. Oncol. 17(10), 3122-3127 (1999). (Pubitemid 29470641)
98. Curtis RE, Rowlings PA, Deeg HJ et al. Solid cancers after bone marrow transplantation. N. Engl. J. Med. 336(13), 897-904 (1997). (Pubitemid 27137189)
99. Bhatia S, Louie AD, Bhatia R et al. Solid cancers after bone marrow transplantation. J. Clin. Oncol. 19(2), 464-471 (2001). (Pubitemid 32112860)
100. Leisenring W, Friedman DL, Flowers ME, Schwartz JL, Deeg HJ. Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation. J. Clin. Oncol. 24(7), 1119-1126 (2006). (Pubitemid 46638809)
101. Schwartz JL, Kopecky KJ, Mathes RW, Leisenring WM, Friedman DL, Deeg HJ. Basal cell skin cancer after total-body irradiation and hematopoietic cell transplantation. Radiat. Res. 171(2), 155-163 (2009).
102. Friedman DL, Rovo A, Leisenring W et al. Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party. Blood 111(2), 939-944 (2008).
103. Cohen A, Rovelli A, Merlo DF et al. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study. J. Clin. Oncol. 25(17), 2449-2454 (2007). (Pubitemid 46999216)
104. Sun CL, Francisco L, Kawashima T et al. Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Blood 116(17), 3129-3139; quiz 3377 (2010).
105. Wingard JR, Majhail NS, Brazauskas R et al. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J. Clin. Oncol. 29(16), 2230-2239 (2011).
106. Martin PJ, Counts GW Jr, Appelbaum FR et al. Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. J. Clin. Oncol. 28(6), 1011-1016 (2010).
107. Bishop MM, Lee SJ, Beaumont JL et al. The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls. Biol. Blood Marrow Transplant. 16(2), 207-214 (2010).
108. Armenian SH, Sun C-L, Kawashima T et al. Long-term health-related outcomes in survivors of childhood cancer treated with hematopoietic cell transplantation (HSCT) versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS).Blood DOI: 10.1182/blood-2011-01-331835 (2010) (Epub ahead of print).
109. Shankar SM, Carter A, Sun CL et al. Health care utilization by adult long-term survivors of hematopoietic cell transplant: report from the Bone Marrow Transplant Survivor Study. Cancer Epidemiol. Biomarkers Prev. 16(4), 834-839 (2007). (Pubitemid 46650591)
110. Rizzo JD, Wingard JR, Tichelli A et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol. Blood Marrow Transplant. 12(2), 138-151 (2006). (Pubitemid 43138009)